Technology Insider | Manufacturing | Biomanufacturing
As the COVID-19 pandemic intensified across the globe in April 2020, and many cities and states shut down, Professor J. Christopher Love and his team returned to the MIT Love Lab to critical path work--developing a vaccine candidate for COVID-19.
